smallmolecul
stabil
interact
ppi
extrem
promis
strategi
drug
discoveri
use
treat
cancer
viral
stabil
ppi
small
molecul
may
alloster
direct
also
call
orthoster
process
alter
oligomer
equilibrium
protein
enabl
small
molecul
modul
physiolog
anticanc
drug
paclitaxel
exampl
alloster
enhanc
microtubul
structur
assembl
bind
hand
rapamycin
anoth
anticanc
agent
bind
directli
interfac
mtor
stabil
structur
wellcharacter
ppi
suitabl
target
drug
develop
form
nativ
physiolog
condit
howev
nonn
interact
may
form
extrem
circumst
insid
crystal
lattic
also
potenti
drug
target
exampl
nucleozin
exert
antivir
activ
stabil
nonn
ppi
interfac
two
neighbor
nucleoprotein
trimer
within
influenza
viru
result
abnorm
protein
oligomer
loss
viral
middl
east
respiratori
syndrom
coronaviru
merscov
belong
betacoronaviru
famili
caus
sever
respiratori
distress
high
mortal
rate
recent
close
relat
novel
coronaviru
coronaviru
diseas
caus
outbreak
pneumonia
wuhan
underscor
risk
cov
global
public
howev
effect
treatment
cov
thu
urgent
need
develop
new
antivir
agent
merscov
packag
genom
nucleocapsid
n
protein
form
ribonucleoprotein
rnp
complex
rnp
essenti
viral
transcript
assembl
sever
studi
suggest
modul
cov
n
protein
oligomer
small
molecul
feasibl
antivir
drug
develop
cov
n
protein
organ
ntermin
domain
ntd
ctermin
domain
ctd
domain
particip
rna
cov
nntd
structur
fold
monomer
conform
contrast
cov
nctd
alway
dimer
respons
n
protein
oligomer
via
report
crystal
structur
merscov
nntd
nonn
dimer
configur
use
nonn
dimer
interfac
target
virtual
screen
orthoster
stabil
end
consid
bind
score
hydrophob
complementar
acquir
pose
select
potenti
lead
acro
zinc
drug
databas
antivir
stabil
activ
n
protein
smallangl
xray
scatter
sax
cellbas
assay
show
induc
abnorm
fulllength
n
protein
oligomer
vitro
cell
level
also
describ
structur
merscov
nntd
complex
reveal
stabil
mechan
find
provid
insight
develop
new
therapeut
approach
base
stabil
nonn
protein
interact
interfac
may
lead
discoveri
develop
new
treatment
variou
infecti
diseas
determin
crystal
structur
merscov
nntd
molecular
replac
mr
use
structur
nntd
pdb
id
search
final
structur
refin
rfactor
rfree
valu
respect
resolut
tabl
asymmetr
unit
contain
four
nntd
molecul
assembl
two
ident
dimer
overal
rmsd
dimer
figur
b
monom
share
similar
structur
core
preced
flexibl
region
figur
core
consist
fivestrand
antiparallel
sandwich
loop
arrang
righthand
fistshap
structur
conserv
among
structur
howev
loop
connect
strand
protrud
core
cov
n
protein
absent
unlik
report
structur
monomer
conform
structur
atyp
dimer
figur
show
detail
interact
merscov
n
protein
dimer
name
unit
monom
monom
figur
accord
amino
acid
composit
bind
site
monom
divid
dimer
interfac
two
area
one
locat
nterminu
flexibl
region
loop
n
protein
first
area
monom
gener
conserv
hydrophob
pocket
permit
side
chain
monom
enter
hole
hydrophob
contact
figur
monom
pack
monom
respect
contribut
hydrophob
interact
side
chain
monom
form
one
hydrogen
bond
backbon
monom
distanc
second
area
rel
hydrophil
main
chain
oxygen
monom
form
three
hydrogen
bond
side
chain
monom
distanc
respect
side
chain
monom
form
hydrogen
bond
main
chain
oxygen
monom
distanc
interact
first
second
area
compris
buri
surfac
area
bsa
respect
small
surfac
area
buri
interfac
account
kcal
bind
translat
dissoci
constant
mm
thu
dimer
describ
uniqu
nonn
reli
vectorfus
residu
maintain
dimer
statu
properti
may
also
explain
present
structur
oligomer
statu
differ
previous
report
structur
cov
n
use
crosslink
experi
analyz
oligomer
capac
mer
nntd
contain
vectorfus
residu
solut
mer
nntd
dimer
conform
solut
structur
indic
play
essenti
role
form
hydrophob
pocket
accommod
vectorfus
residu
therefor
mediat
nntd
dimer
format
mutat
significantli
reduc
oligomer
tendenc
nntd
figur
support
exogen
residu
encod
vector
backbon
mediat
format
nonn
dimer
also
superimpos
previous
publish
structur
merscov
nntd
pdb
id
contain
nativ
ntermin
flexibl
region
dimer
structur
side
chain
nativ
structur
could
interact
hydrophob
pocket
former
hydrophil
short
figur
thu
may
possibl
util
small
compound
replac
vectorfus
residu
stabil
ppi
hydrophob
interact
perform
structurebas
virtual
screen
target
hydrophob
pocket
nntd
dimer
interfac
remov
templat
identifi
compound
could
replac
vectorfus
residu
therefor
contribut
stabil
effect
figur
b
chose
highestscor
hit
list
tabl
base
shape
complementar
presenc
aromat
moieti
abil
stack
onto
nntd
format
nonn
dimer
primarili
mediat
hydrophob
interact
structur
figur
next
consid
hydrophob
complementar
acquir
ligand
nntd
form
lipophil
match
surfac
sll
also
took
account
abil
drug
permeat
cell
aim
lower
topolog
polar
surfac
area
tpsa
base
criteria
three
compound
final
chosen
studi
hydroxymethyl
higher
sll
dock
score
lower
tpsa
clinic
drug
etodolac
compar
sll
lower
dock
score
select
candid
howev
induc
compar
larger
blue
shift
intrins
nntd
fluoresc
spectrum
indic
microenviron
surround
tryptophan
protein
increas
rigid
hydrophob
presenc
result
also
indic
bound
tightli
n
protein
interact
pocket
figur
fluoresc
thermal
stabil
assay
disclos
nntd
denatur
melt
temperatur
increas
ad
sigmoid
melt
curv
merscov
nntd
chang
presenc
delay
protein
denatur
suggest
stabil
merscov
nntd
dimer
structur
figur
measur
cytotox
concentr
effect
concentr
compound
use
vero
cell
infect
merscov
tabl
show
favor
therapeut
index
among
lead
compound
test
studi
therefor
excel
candid
inhibitor
merscov
use
sax
assess
effect
fulllength
merscov
n
protein
structur
fit
distanc
distribut
function
protein
without
shown
figur
increas
maximum
dimens
dmax
radiu
gyrat
rg
protein
respect
thu
size
merscov
n
protein
solut
alter
upon
bind
presenc
multipl
intrins
disord
region
n
protein
preclud
determin
structur
xray
crystallographi
instead
use
rigid
bodi
model
sax
data
ntermin
domain
ntd
solv
studi
ctermin
domain
ctd
pdb
id
way
obtain
structur
model
free
n
protein
complex
figur
c
excel
fit
obtain
repres
structur
model
fulllength
protein
without
shown
figur
e
respect
free
n
protein
form
tetram
ctd
ntd
freeli
hang
solut
figur
conform
solut
consist
structur
previous
report
cov
n
complex
form
compact
hexadecam
sunburst
configur
figur
ctd
form
central
ring
nonn
ntd
dimer
form
spike
protrud
ring
consist
ligandinduc
aggreg
observ
blue
shift
fluoresc
spectrum
fulllength
merscov
n
protein
presenc
figur
addit
also
delay
n
protein
thermal
denatur
chang
shape
denatur
curv
suggest
larg
protein
aggreg
form
presenc
figur
structur
explain
nntd
dimer
decreas
merscov
viabil
n
protein
packag
viral
genom
rnp
complex
sever
model
nctd
dimer
assembl
propos
format
filament
propos
interfac
nctd
dimer
occur
sidefac
ctd
cuboid
perpendicular
propos
rnabind
surfac
figur
combinatori
use
region
sidefac
ctd
dimer
cuboid
may
facilit
manipul
rnp
length
curvatur
without
obstruct
rnabind
howev
sax
result
indic
nctd
aggreg
occur
floor
ctd
cuboid
reason
rnabind
surfac
ctd
occlud
neighbor
ctd
ring
nonn
ntd
dimer
make
direct
contact
ctd
figur
addit
ctd
cuboid
aggreg
natur
form
topolog
close
octam
leav
open
end
addit
ctd
cuboid
form
long
filament
rnp
loss
rnabind
surfac
inabl
incorpor
n
protein
molecul
beyond
octam
may
inhibit
format
rnp
therefor
may
inhibit
merscov
rnp
format
induc
n
protein
aggreg
demonstr
best
characterist
therapeut
candid
determin
antimerscov
activ
cell
effect
incub
extracellular
viral
titer
intracellular
viral
rna
level
assess
plaqu
assay
vero
cell
figur
rtqpcr
figur
respect
margin
affect
viral
titer
h
suppress
viral
rna
replic
halt
viral
product
replic
h
result
prove
capac
antivir
compound
examin
merscov
n
protein
distribut
express
infect
cell
without
treatment
confirm
sax
find
immunofluoresc
microscopi
figur
show
condens
intracellular
n
protein
fluoresc
signal
infect
vero
cell
treat
thu
may
induc
intracellular
n
protein
aggreg
suppress
n
protein
express
cell
howev
present
intens
n
protein
signal
may
restrain
merscov
n
protein
insid
infect
cell
promot
format
new
virion
could
releas
way
adjac
cell
could
infect
merscov
data
therefor
suggest
may
inhibit
merscov
induc
abnorm
aggreg
n
protein
insid
cell
find
consist
result
structurebas
assay
attempt
obtain
crystal
merscov
nntd
complex
compound
cocrystal
ligandsoak
except
complex
structur
nntd
solv
resolut
respect
tabl
overal
structur
complex
resembl
apomerscov
complex
reveal
welldefin
unbias
densiti
dimer
interfac
permit
detail
analysi
interact
compound
merscov
nntd
figur
interact
n
protein
compound
calcul
discoveri
studio
client
interact
hydrophob
contact
consist
select
rational
complex
monom
monom
pack
creat
dimer
figur
addit
two
nonbond
interact
detect
monom
interact
benzen
ring
indolin
moieti
monom
also
hydrogen
bond
benzen
ring
side
chain
monom
figur
rel
bound
deepli
dimer
interfac
interact
larger
number
residu
nntd
monom
amino
acid
composit
bind
region
monom
monom
residu
along
gener
massiv
hydrophob
drive
forc
allow
protein
ligand
pack
stabil
dimer
conform
n
protein
figur
sever
nonbond
interact
also
observ
site
includ
interact
benzen
ring
monom
monom
via
pair
interact
dimethylaminomethyl
moieti
major
sourc
nonbond
interact
three
interact
form
moieti
aromat
group
monom
moieti
also
form
pair
interact
interact
monom
figur
structur
analys
explain
compar
stronger
bind
nntd
figur
corrobor
thermal
stabil
effect
figur
antivir
activ
tabl
compound
use
small
molecul
stabil
ppi
interfac
shown
viabl
approach
develop
new
therapeut
compound
creat
structurebas
design
manipul
ppi
depend
detail
knowledg
nativ
interact
contrast
compound
therapeut
potenti
stabil
nonn
ppi
interfac
discov
chanc
antiinfluenza
compound
nucleozin
initi
discov
use
chemic
genet
approach
abil
stabil
nonn
nucleoprotein
oligom
elucid
much
swinholid
cytotox
marin
macrolid
known
disrupt
actin
cytoskeleton
act
anticanc
agent
took
ten
year
discov
stabil
gactin
nonn
homodim
howev
exampl
underscor
import
hydrophob
crucial
factor
stabil
demonstr
possibl
use
hydrophob
interact
nonn
interfac
target
virtual
screen
combin
suitabl
select
criteria
focus
shape
hydrophob
complementar
ligand
receptor
smallmolecul
compound
stabil
nonn
ppi
may
identifi
ration
manner
use
approach
success
identifi
compound
affect
biochem
activ
target
protein
show
efficaci
target
pathogen
merscov
figur
nonn
merscov
nntd
dimer
induc
abnorm
n
protein
aggreg
influenc
oligomer
behavior
nctd
eventu
halt
function
rnp
format
best
knowledg
structurebas
strategi
target
nonn
interfac
never
propos
therapeut
design
thu
nonn
interact
interfac
protein
may
compris
new
drug
develop
target
class
merscov
amino
acid
compris
nonn
interact
interfac
nntd
rel
conserv
hydrophob
pocket
surround
monom
share
among
interact
surfac
monom
includ
also
highli
conserv
figur
conserv
may
provid
certain
advantag
develop
compound
broadspectrum
activ
target
pathogen
famili
includ
test
mous
hepat
viru
mhv
observ
reduct
viral
titer
indic
may
also
inhibit
mhv
replic
figur
hand
target
nonn
interact
interfac
trivial
interfac
format
induc
extern
agent
comput
aim
predict
nativ
ppi
structur
may
abl
identifi
potenti
nonn
interfac
nevertheless
sever
stratagem
may
assist
identif
potenti
nonn
interact
interfac
one
strategi
search
target
protein
structur
crystal
pack
contact
known
biolog
irrelev
anoth
approach
identifi
weakli
interact
site
nmr
chemic
shift
perturb
hydrogendeuterium
exchang
potenti
nonn
interact
interfac
identifi
standard
screen
function
character
may
conduct
small
compound
bind
interfac
summar
demonstr
nonn
interact
interfac
might
form
protein
abnorm
oligomer
use
merscov
n
protein
exampl
show
nonn
interfac
might
serv
target
smallmolecul
structurebas
screen
also
propos
sever
stratagem
ration
identifi
potenti
nonn
interfac
target
screen
believ
discov
test
altern
drug
discoveri
paradigm
could
help
expand
repertoir
lead
compound
variou
pathogen
compound
purchas
maybridg
chemic
compani
tci
chemic
sigmaaldrich
corpor
respect
reagent
use
studi
purchas
sigma
chemic
co
st
loui
mo
puriti
compound
higher
use
without
purif
merscov
n
protein
prepar
accord
previous
describ
brief
cdna
fragment
merscov
n
protein
clone
express
vector
merck
darmstadt
germani
contain
histidin
tagencod
sequenc
vector
encod
singl
mutant
gener
use
quikchang
sitedirect
mutagenesi
protocol
primer
list
tabl
vector
transform
escherichia
coli
plyss
cell
cell
grown
optic
densiti
rang
nm
protein
express
induc
mm
isopropyl
iptg
follow
incub
h
cell
harvest
centrifug
min
resuspend
lysi
buffer
mm
nacl
mm
trishcl
mm
imidazol
mm
pmsf
ph
cell
lyse
sonic
centrifug
min
remov
debri
supernat
purifi
inject
column
merck
darmstadt
germani
elut
buffer
contain
imidazol
gradient
rang
mm
pure
protein
fraction
collect
dialyz
lowsalt
buffer
concentr
quantifi
bradford
method
bioshop
canada
inc
burlington
canada
merscov
nntd
crystal
grown
previous
merscov
nntd
crystal
room
temperatur
sittingdrop
vapordiffus
method
protein
solut
mg
mix
equal
volum
crystal
solut
consist
mm
ammonium
sulfat
mm
nabr
peg
sigmaaldrich
corp
st
loui
mo
equilibr
solut
merscov
nntd
cocryst
obtain
use
crystal
solut
contain
mm
merscov
nntd
crystal
complex
obtain
soak
nativ
merscov
nntd
crystal
room
temperatur
crystal
solut
contain
mm
diffract
dataset
merscov
nntd
alon
complex
collect
beamlin
taiwan
light
sourc
tl
nation
synchrotron
research
center
nsrrc
hsinchu
citi
taiwan
diffract
merscov
nntd
complex
perform
beamlin
hyogo
japan
diffract
data
process
scale
softwar
structur
solv
molecular
replac
mr
use
nntd
search
initi
model
rebuilt
refin
phenix
structur
visual
use
pymol
pymol
molecular
graphic
system
version
protein
solut
contain
wildtyp
mutat
merscov
nntd
incub
glutaraldehyd
final
concentr
vv
reaction
conduct
room
temperatur
min
quench
addit
trishcl
ph
sampl
store
ice
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
screen
compound
induc
hydrophob
ppi
mer
nntd
model
dimer
merscov
nntd
without
residu
use
virtual
drug
screen
sigmaaldrich
acro
organ
zinc
drug
databas
screen
libdock
molecular
dock
softwar
obtain
compound
act
n
protein
n
protein
bind
pocket
repres
set
sphere
compound
databas
dock
pocket
compris
hydrophob
complementar
ligand
receptor
calcul
compound
higher
dock
score
list
tabl
fluoresc
assay
perform
buffer
consist
mm
trishcl
ph
mm
nacl
one
micromolar
n
protein
incub
either
control
buffer
compound
h
tryptophan
fluoresc
acquir
jasco
fluoresc
spectromet
jasco
intern
co
ltd
tokyo
japan
excit
wavelength
nm
emiss
wavelength
rang
nm
thermost
assay
conduct
buffer
consist
mm
trishcl
ph
mm
nacl
jasco
fluoresc
spectromet
jasco
intern
co
ltd
tokyo
japan
one
micromolar
n
protein
incub
either
control
buffer
compound
h
uv
absorb
vs
temperatur
profil
acquir
ramp
temperatur
record
absorb
nm
everi
min
vero
cell
infect
merscov
moi
treat
lead
compound
h
cell
viabil
determin
neutral
red
uptak
assay
determin
cell
viabil
determin
cell
treat
drug
determin
mersinfect
cell
drug
treatment
sax
experi
perform
sax
beamlin
tl
nsrrc
use
monochromat
xray
beam
integr
hplc
system
agilentbio
column
agil
technolog
inc
santa
clara
ca
protein
sampl
merscov
n
merscov
n
complex
prepar
incub
nativ
protein
prepar
buffer
consist
mm
trishcl
ph
mm
nacl
ice
h
aliquot
inject
column
flow
rate
ml
pass
column
sampl
solut
direct
quartz
capillari
mm
dia
subsequ
buffer
sampl
sax
measur
k
sampletodetector
distanc
use
cover
scatter
vector
q
rang
q
defin
q
sin
scatter
angl
thirtysix
frame
collect
sampl
elut
xray
frame
exposur
time
frame
good
data
overlap
name
low
radiat
damag
effect
merg
improv
data
statist
analyz
determin
initi
rg
use
primu
version
p
r
distanc
distribut
dmax
calcul
experiment
scatter
curv
use
gnom
version
ensembl
optim
method
eom
analysi
perform
embl
hamburg
web
model
rigid
bodi
crystal
structur
calcul
gener
use
crysol
atsa
program
suit
v
crystal
structur
merscov
ntd
pdb
id
merscov
ntd
solv
studi
ctd
domain
merscov
n
protein
pdb
id
use
rigid
bodi
eom
analysi
eom
analysi
model
gener
begin
structur
pool
select
sax
profil
structur
pool
ensembl
model
could
fit
experiment
scatter
curv
linear
combin
tetramer
merscov
np
conform
merscov
conform
select
ensembl
gener
curv
fit
best
experiment
sax
result
vero
cell
atcc
seed
onto
cultur
plate
complet
dulbecco
modifi
eagl
medium
dmem
incub
overnight
prior
infect
merscov
multipl
infect
moi
ad
cell
incub
h
follow
wash
thrice
phosphatebuff
salin
pb
remov
unattach
viru
fresh
complet
cultur
medium
ad
plate
vero
cell
seed
plate
incub
overnight
assay
sampl
contain
merscov
serial
dilut
mem
ad
well
incub
h
agit
everi
min
incub
inocula
remov
wash
pb
overlay
medium
compris
mem
wv
agaros
ad
well
follow
incub
day
plate
fix
vv
formalin
contain
wv
crystal
violet
plaqu
count
total
rna
infect
vero
cell
extract
rneasi
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
revers
transcript
pcr
amplif
perform
itaq
univers
onestep
rtqpcr
kit
biorad
laboratori
hercul
ca
realtim
pcr
perform
steponeplu
realtim
pcr
system
appli
biosystem
foster
citi
ca
primer
pair
use
amplifi
viral
rna
follow
gapdhf
gapdhr
merscovf
merscovr
mer
rna
level
normal
gapdh
compar
merscov
group
hpi
hpi
vero
cell
seed
eightwel
chamber
slide
incub
overnight
prior
infect
merscov
moi
cell
fix
vv
paraformaldehyd
min
follow
permeabil
vv
triton
min
vv
bsa
use
block
buffer
min
antimerscov
n
primari
antibodi
dilut
sino
biolog
inc
beij
china
use
stain
viru
cell
incub
overnight
wash
thrice
pb
incub
alex
fluor
antirabbit
secondari
antibodi
dilut
thermo
fisher
scientif
waltham
h
room
temperatur
dapi
ad
pb
wash
mer
nucleocapsid
express
examin
confoc
microscop
carl
zeiss
ag
oberkochen
germani
